The most critical pieces of information are the precise location and extent of cancer within the prostate. I can’t think of anything more important. Right now, there is no proven method. We need that desperately. – Patrick Walsh, MD, Professor of Urology, Johns Hopkins University

 

At its current state, prostate cancer care is blind. If you can’t see, you can’t treat.

Our research programs are uniquely dedicated to the creation of Manograms®, life-saving diagnostic imaging tools for men, which will end the era of blind patient care and create the future of precisely-targeted, minimally-invasive biopsies and treatment.

Just as mammography has transformed breast cancer care, Manograms® will enable:

• Precise guidance of biopsies for improved early detection of aggressive prostate cancer critical for saving lives;

• Elimination of unnecessary procedures for benign or dormant disease, which is not likely to cause symptoms in a man’s lifetime;

• Replacement of radical surgery with image-guided, minimally invasive treatment, which will be performed in outpatient clinics with reduced complications, discomfort and costs (“male lumpectomy”).

For more information about how advanced imaging technologies (the Manogram®) will change the future of prostate care, read about the prostate cancer crisis here.